中国药学杂志英文版杂志投稿须知

中国药学杂志投稿须知中国药学杂志稿约本刊为中国药学会主办、国内外公布发行的综合性药学学术刊物（半月刊），是一本反映我国药学各学科进展和动态的专业性学术期刊，以高、中级药学工作者及其他医药卫生人员为读者对象。

本刊内容包括药学各学科，如生物技术、药剂学、临床药学、药理学、药品检验学、药物化学、生化药学、中药学、天然药物学等，辟有专家笔谈、综述、论著、知识介绍、药物与临床、新药评述、药学史、药学人物、药事治理、学术讨论、知识介绍、科研简报、科技园地、编读园地、学术动态等栏目。

本刊连续三届荣获国家期刊奖，并入选为中国精品科技期刊。

本刊为中国科技论文统计源期刊(中国科技核心期刊)、《中文核心期刊要目总览》药学类核心期刊，并被美国《化学文摘》(CA)、荷兰医学文摘、国际药学文摘(IPA)等国际重要检索系统收录。

2006~2007年连续两年获“中国科协精品科技期刊工程项目”B类资助，并获得“2007年百种中国杰出学术期刊”称号。

进入中国知网（CNKI）光盘版、网络版。

表格用三线表，两端开口，不用纵线；栏头左上角不用斜线；除栏头外，表身中不用或少用横线；表内尽可能不用或少用标点符号；上、下行的数字最好对齐；表内计量单位的名称要使用单位符号。

表格最好设计成单栏表，表宽的字数(包括空格和直列与直列间空格在内)不超过33字。

表注依序用1)，2)，3)……表示，写在右上角。

曲线一样应经曲线拟合(curve fitting)，并尽可能“直线化”，例如通过对数(lg)、倒数(reciprocal)、概率单位(probit)、算出单位(logit)等转换。

直线应按照回来方程绘图。

如有图注者应在稿内图位的框线下写明：1-……；2-……；3-……，或者A-……；B-……；C-……。

照片用黑白片，必须反差鲜亮，清晰易辨，常用大小为127 mm×178 mm。

显微镜照片内应画长度标尺，如|—|，示1 μm，必要时，以↑标明上方位。

药学学报英文版投稿经验
以下是药学学报英文版投稿经验：
1. 了解期刊要求：在投稿前，详细阅读药学学报英文版的投稿指南，了解其对稿件的具体要求，如研究类型、研究方法、数据呈现等。

这有助于确保稿件格式正确，提高被接受的几率。

2. 选择合适的期刊：根据研究成果和目标受众选择合适的期刊。

药学学报英文版主要关注药学的最新研究成果，如果是相关领域的成果，建议投稿。

3. 撰写高质量的稿件：确保稿件内容清晰、逻辑严谨、数据可靠。

使用科学的方法和语言撰写摘要和关键词，使国际读者也能理解研究的重要性和意义。

4. 遵循投稿指南：投稿时严格遵循期刊的投稿指南，包括文件格式、提交材料等。

这有助于提高稿件的初步筛选通过率。

5. 反复修改稿件：完成稿件后，多次阅读并修改，确保语言准确、无语法错误。

同时，确保研究方法和结论表述清晰，使审稿人能准确理解研究内容。

6. 及时回复审稿意见：如果稿件被接受，作者需要及时回复审稿人的意见和建议，对稿件进行必要的修改。

这有助于提高稿件的质量，增加被接受的几率。

7. 保持与编辑的沟通：在整个投稿过程中，作者可以随时与编辑沟通，了解稿件的审稿进度和结果。

这有助于作者更好地了解稿件的状态，为后续的修改和再投稿做准备。

以上是药学学报英文版投稿的一些经验，仅供参考。

在实际操作中，作者需要根据具体情况进行调整。

《中国医院药学杂志》修改稿件注意事项请逐项阅读并对照检查文章内容，如有不符之处请加以修改或补充。

1. 修改说明：为了便于了解稿件的修改情况，请您：(1) 在修改稿寄回时应另页逐条回答审稿人提出的问题,说明是否接受审稿人的意见并在文章中作了相应的修改，如果不同意审稿人的意见或未作修改，请提出理由。

发送时修改稿和问题回答应是一个文件。

(2) 为了不使读者产生与审稿人相同的疑问，所作的说明或解释同意修改的应尽可能反映在稿件中，而不应只写在给编辑部的回信中。

2. 文章标题：文章题目应明确简洁地反映研究成果的实质和特点，长短适宜，不使用不规范的缩略语、符号和代号，药物名请采用通用名或药典名，中英文标题应尽可能保持一致。

3. 作者信息：（1）作者的工作单位应写标准全称，如要更改第一作者或第一作者单位，应提供情况说明并重开单位介绍信。

（2）中英文中的所有作者名称请写全，并注明所有作者的单位。

(3) 请提供第一作者或/和通讯作者简介，包括性别、学位和职称、研究方向、联系电话和E-mail(方便的话也请提供移动电话，便于编辑部联系，文章发表时原则上不出现移动电话号码)。

(4) 基金资助项目的基金名称和项目批准号。

提供纸样复印件。

4. 文章摘要：（1）除药物不良反应栏目外，所有论文均需英文文题、摘要及关键词（2）摘要应客观充分地反映文章的新意和主要内容，并与正文相符。

请按目的、方法、结果和结论的顺序撰写，详略得当（综述文章可以不用这种格式）。

目的用1～2句概括即可；方法应给出足够的信息，新方法应加以详细描述；重要的实验结果应给出具体数据。

(3) 摘要中不应引用图表和参考文献。

（4) 缩写词在第一次出现时先给出全称，然后在括号中注明缩写，后面就用缩写表示，尽量不要中文和缩写混用。

(5) 如果作者在英文写作上有困难，请务必找英文较好的人帮助撰写或校对。

(6) 稿件需3～8个关键词，中英文关键词应完全一致5.前言书写：请作者重视前言部分的撰写，注意事项如下：(1) 在前言中简要介绍国内外相关研究的历史和现状，引出有代表性的参考文献，特别是近2～3年的最新进展；说明本文的研究目的、拟解决的问题及采用的方法和手段。

《中国药房》投稿须知信息来源：《中国药房》杂志《中国药房》杂志是中华人民共和国卫生部主管，中国医院协会、中国药房杂志社主办的国家级、国内外公开发行的药学技术类刊物；创刊于1990年，周刊；现为全国中文核心期刊、中国科技论文统计源期刊、中国科技论文核心期刊。

杂志以构建药品研制、生产、经营、临床应用及监督管理间的桥梁为己任。

读者对象主要为从事医院药房（药剂科）、社会药房（店）工作的各级各类人员以及药品研制、生产、经营、临床应用和监督管理人员。

主要栏目：第一周刊为“药房与药事”专题，主要栏目包括：医药热点、药业专论、药事管理、实验研究、药房管理、制剂与工艺、药品检验、新药与辅料、药师之友、药店与执业药师、综述讲座等；第二周刊为“药房与临床”专题，主要栏目包括：专家论坛、药物警戒与干预、药物经济学、用药分析、临床药学、药物与临床、不良反应监测、药物配伍、药师与临床、药学服务、综述讲座等；第三周刊为“药房与中药”专题，主要栏目包括：中药论坛、中药研究、中药工艺与制剂、中药临床、中药分析与鉴定、中药资源与栽培、中药视窗、综述讲座等；第四周刊为“药房与基本药物”专题，主要栏目包括：医药政策、基本药物论坛、调查分析、药品价格、药品招投标、基本药物配送、基本药物应用、基本药物检定、基层医药、药学教育、综述讲座等。

1 稿约内容主要有：业界普遍关注的热点、焦点问题；对医药行业有指导意义的理论研究；原始实验研究；医药市场动态分析与预测以及与市场有关的“大政小事”；医院药房（药剂科）管理经验交流；药物经济学方法学研究和应用实践；大样本的医院用药情况分析；新药、进口药品临床药理；合理用药资料总结；药品的监督、检验、不良反应监测工作探讨；新药或药学新进展综述；海外药房事务；中药房业务；医药工、商企业及品种介绍；药店管理、经营经验介绍；继续医学教育，等等。

2 投稿注意事项2.1 文稿应具科学性、前瞻性、逻辑性、实用性和指导性。

Instructions for authorsChinese Medical Journal (CMJ) is an international, peer-reviewed general medical journal published in English semimonthly by the Chinese Medical Association and distributed worldwide. Manuscripts are welcome from any part of the world.MANUSCRIPT INFORMATIONManuscript requirementsManuscripts submitted to CMJ should meet the following criteria: the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data.Manuscript submissionAuthors are required to submit their manuscripts online at .Previous publication or duplicate submissionManuscripts are considered with the understanding that they have not been published previously and are not under consideration by another publication. Copies of possibly duplicative materials that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.Previous presentationA complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) can be considered.CATEGORIES OF ARTICLESCMJ publishes editorial, original article, review article, medical progress, brief report,viewpoint, case report, letter, and many other categories of articles. Topics of interest include all subjects that relate to the practice of medicine and research.EditorialThese are usually commissioned, however, unsolicited editorials are welcome. We are keen to consider editorials or ideas for editorials from authors outside China. Editorials should be up to 2000 words long with no more than 25 references.Original articleManuscripts on epidemiological studies, studies of social medicine, clinical trials, especially large scale randomized controlled trials are welcome. Each manuscript should clearly state an objective or hypothesis, the methods, the main results of the study and the conclusions. The length is limited to 2000–4000words (not including tables, figures, and references).More than 20 references are encouraged to be cited in this kind of articles.Meta analysisOnly results of meta analysis are reported in this kind of article. The length of the article is within 2000–4000 words (not including tables, figures, and references). Medical progressThis kind of article is mainly solicited, but we also consider unsolicited articles. The length of the article is within 2000–4000 words (not including tables, figures, and references).Review articleReview articles include systematic, critical assessments of literature and data sources pertaining to different medical topics, such as cause, diagnosis, prognosis, therapy, or prevention, etc.The length is limited to 2000–4000words (not including tables, figures, and references).Brief reportThese articles are short reports of original studies. They should not exceed 2500 words with no more than 2 tables and/or two illustrations and 15 references.Clinical experienceAuthors of these articles provide their experiences for diagnosis, treatment or prevention of diseases. The length is up to 2500 words with no more than 2 tables and/or two illustrations and 15 references.ViewpointPersonal views are welcome and the length should be 1000–3000 words (not including tables, figures, and references). Authors of this type of articles should sign their real names; no anonymous pieces are published.Case reportAuthors usually describe one to three patients or a single family. The text is limited to no more than 2500 words, and up to 15 references.Clinical solutionsThe articles are evidence-based reviews of topics relevant to practicing physicians. Articles in this series should include the following sections: case report, clinical overview, strategies, clinical difficulties, and author’s personal opinions. The text is limited to 3000 words and a small number of figures and tables. Images for diagnosisAuthors can provide here with typical images of common or uncommon medical conditions. This feature is intended to capture the sense of visual discovery and variety that physicians experience. It is not intended as a vehicle for case reports.LetterLetters to editors discussing a recent CMJ article should be received within 3 months of the article’s publication and should not exceed 500 words of text and 5 references. Letters should also be submitted online.AUTHOR INFORMATIONDesignate a corresponding author and provide a complete address,telephone and fax numbers, and E-mail address.Authorship requirementsEach author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based on(1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published.Conditions 1, 2, and 3 must all be met.1Group authorshipIf authorship is attributed to a group, all members of the group must meet the full criteria and requirements for authorship as described above. A group must designate at least one individual as corresponding author. Other group members may be listed in an Acknowledgment.Conflicts of interestAuthors should indicate relevant conflicts of interest, including specific financial interests relevant to the subject of their manuscript, in their covering letter. Authors without relevant financial interests in the manuscript should indicate no such interest.EDITORIAL REVIEW AND PUBLICATIONPeer reviewA CMJ editor reviews submitted manuscripts initially. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential.The manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. Rejected manuscriptsRejected manuscripts and reasons for rejection can be found online. EditingAccepted manuscripts are copyedited first by native speakers and then by CMJ editors according to CMJ style and returned to the author for approval. Authors are responsible for all statements made in their work, including changes made by the editor and authorized by the corresponding author.PublicationAuthors are required to pay page fee if their manuscripts are accepted for publication. The publisher will provide the author (s) 2 copies of the journal free of charge.CopyrightThe Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of the Chinese Medical Association and may not be published elsewhere without written permission. Chinese Medical Association keeps the right to use these manuscripts in any form, including print, video, audio, and digital.MANUSCRIPT PREPARATIONManuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by the International Committee of Medical Journal Editors (ICMJE) ().Submit the original manuscript online; use 1 side of standard-sized page and 1.5 cm margins.For Chinese authors, submission of a Chinese version of the manuscript (or abstract) is recommended.Use only 10- or 12-point font size.On the title page include the full names and affiliations of all authors. If an author’s affiliation has changed since the work was done, list the new affiliation as well. Titles should be concise and descriptive. The name, address, telephone number, fax number, and E-mail address of the correspondence author should be addressed. Any grant support that requires acknowledgment should be mentioned on this page.Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury. All hematological and clinical chemistry measurements should be reported in the metric system in terms of the International System Units (SI).Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is directly relevant to the discussion.Do not use abbreviations in the title or abstract and limit their use in the text.A covering letter signed by all authors includes(1) information on prior or duplicate publication or submission elsewhere of any part of the study; (2) the statement that the manuscript has been read and approved by all the authors and that the criteria for authorship have been met; (3) the statement on financial or other conflict of interests; and (4) any suggestions such as referring possible unqualified reviewers due to conflict of interests, etc. The corresponding author must sign the acknowledgment statement. Authors should obtain written permission from all individuals named in an acknowledgment.JOURNAL STYLETablesTables should be simple and no duplicate information should appear in the text of the article. Tables should be numbered consecutively, and headed by a concise title. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Forfootnotes use the following symbols in this sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡.FiguresComplete sets of illustrations must be submitted with legends typed on the same page. Only clear photographs are acceptable. All lettering must be legible after reduction to column size. Magnification and staining should be indicated when pertinent. AbbreviationsUse only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.Ethical requirementFor experimental investigations of human subjects, state in the Methods section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees,the principles outlined in the Declaration of Helsinki2 should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants.Patient descriptions, photographs, and pedigreesInclude a signed statement of informed consent to publish (in print and online) patient descriptions, photographs, and pedigrees from all persons (parents or legal guardians for minors) who can be identified in such written descriptions, photographs, or pedigrees. Such persons should be shown the manuscript before its submission.Permissions required to reproduce or adapt material Acknowledge all text, illustrations, and tables adapted or reproduced from other publications and submit permission from the original publishers(or other copyright owner) to republish in print, online, and licensed versions of CMJ.ReferencesNumber references in the order they appear in the text; do not alphabetize. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references,abbreviate titles of journals according to Medline. Note: List authors and/or editors up to 6; if more than 6, list the first 6 authors followed by et al.Examples of reference style:1. Liu XP, Long DY, Dong JZ, Liu XQ, Fang DP, Hao P, et al. Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein a blation: What’s the difference? Chin Med J 2005; 118: 1773-1778.2. Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm. Chin J Obstet Gynecol (Chin)* 1998; 33: 113-114.3. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974: 457-472.4. Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11 Suppl 2: s369-s378.5. Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2): 89-97.6. Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32 (Pt 3): 303-306.7. Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-114.8. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. (Accessed April 9, 2003 at http://www.who.int/csr/sarscountry/ 2003_04_04/en/.)*: It is especially needed to note “(Chin)” for articles published in Chinese.Authors are responsible for the accuracy and completeness of their references and for correct citation of the text.REPORT OF ORIGINAL DATAAbstractInclude a structured abstract of no more than 300words for original articles, meta analysis, brief report, clinical experience (Background, Methods, Results, Conclusions) and review articles (Objective, Data sources, Study selection, Results, Conclusions); an informative abstract for medical progress, viewpoint, case report, clinical solutions and images for diagnosis.KeywordsThree to 6 words or short phrases should be provided at the top of the abstract page as keywords. Terms from the medical subject heading (MeSH) list of Medline should be used; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.IntroductionIntroduction should be short and arresting. State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.MethodsDescribe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects.Iden tify the methods, apparatus (list the manufacturer’s name and original country in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate theirlimitations. Identify precisely all drugs and chemicals used, including generic name (s), dose (s), and route (s) of administration.Reports of randomized clinical trials should present information on all major study elements including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors are recommended to refer to the CONSORT Statement 3 for details.ResultsOverall describe the major findings of the study. Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. DiscussionSummarize the major findings. Discuss possible problems with the methods used. Compare your results with previous work. Discuss the clinical and scientific (if any) implications of your findings and their limitations. Suggest further work. Produce a succinct conclusion.MANUSCRIPT CHECKLISTSubmit complete text of your manuscript online (including tables, figures, etc), in addition, domestic authors should submit Chinese version of the complete text or its abstract.Review the sequence: covering letter, title page, key words and abstract, text, acknowledgments, references, tables, legends for illustrations.Check all references for accuracy and completeness. Put references in proper format in numerical order, making sure each is cited in the text.Include written permission from each individual identified as a source for personal communication.Include informed consent forms for identifiable patient descriptions, photographs and pedigrees.Keep copies of everything submitted.Manuscript inquiriesTel:86-10-85158321.Fax:86-10-85158333.Email:***********. cn.REFERENCES1.International Committee of Medical Journal Editors. Uniformrequirements for manuscripts submitted to biomedical journals.(Accessed September 10, 2009 at: )2.World Medical Association. Declaration of Helsinki: Ethicalprinciples for medical research involving human subjects.(Accessed September 6, 2005 at: /e/policy/ pdf/ 17c.pdf)3.Schulz KF, Altman DG, Moher D, for the CONSORT Group.The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (Accessed October 28, 2010 at: http://www.consort- )。

《中国医院药学杂志》征稿函《中国医院药学杂志》是中国药学会主办、中国科协主管的国内外公布发行的医院药学专业性学术期刊，为中国精品科技期刊。

本刊为半月刊，大16开本，80页码，每一个月15，30号出版。

要紧介绍国内外医院药学创新性功效、药学先进技术、临床合理用药、中西药制剂、医院调剂、医院药学学科的科学治理与改革、药学基础知识及理论等。

1 期刊简介中国科学引文数据库，美国《国际药学文摘》，美国《化学文摘（网络版）》，日本《日本科学技术振兴机构中国文献数据库》，中国北大2020版核心期刊，中国科技论文统计源期刊（中国科技核心期刊）。

1996 年被评为中国科协优秀期刊，2001、2006、2020年被评为湖北省优秀期刊，中国科协精品期刊。

中文名称：中国医院药学杂志外文名称：Chinese Journal of Hospital Pharmacy语言：中文类别：出版，医学期刊主管单位：中国科学技术协会主办单位：中国药学会创刊时刻：1981年出版周期：半月刊国内刊号：CN：42-1204/R国际刊号：ISSN：1001-5213邮发代号：38-50出版地：湖北省武汉市2 投稿要求及相关规定1）来稿请通过网上在线点击作者中心进行投稿，该刊不同意纸质投稿和电子邮件投稿。

2）在线投稿后请同时寄稿件审稿费40元(请注明文章编号和文题)以便于稿件及时送审，作者可随时登岸杂志网站进行稿件在线查询。

如想转投请务必和编辑部取得联系，不然造成一稿两投后果由作者负责。

3）作者应付文稿的真实性和保密性负责，并申明未一稿多投。

关于基金项目研究论文请在文章首页末行注明，并写明编号，并提供相关证明的复印件；如系会员请注明会员号。

此类论文将优先审核、优先刊用。

4）对修改稿要求：作者接到稿件修改通知后拟在1个月内修回(请务必对修改稿中的文字、数据、符号进行认真查对，确认无误后再上传至该刊)，同时稿件原稿和修改稿打印一份连同介绍信一路寄回。

《中国中药杂志》投稿须知1投稿要求投稿请登录中国中药杂志网站，要求数据可靠，论点明确，结构严密，层次分明，文字精炼。

来稿请勿两投，并注意保密审查。

2写作要求2.1文题、作者及单位列出文题、作者姓名、工作单位（全称）、地名（省市、县）及邮政编码。

不同工作单位的作者，应在姓名右上角加注阿拉伯数字序号，并在工作单位名称之前加与作者姓名序号相同的序号；责任作者（通信作者）应加注*号。

2.2脚注首页脚注中注明[基金项目]（注明项目名称及编号）、[通信作者]（包括Tel，Fax，Email）。

可简明写出第一作者及通信作者简介，内容包括职务、职称、主要研究方向等。

2.3摘要、关键词投稿论文均应附中英文摘要、关键词（8个以内），不必按照“目的”、“方法”、“结果”、“结论”四要素撰写。

多个关键词之间应用分号分隔。

英文摘要字数多于中文摘要，内容尽量丰富。

2.4前言一般不超过300字，应概述本研究的理论依据、实验基础、研究方法及其文献来源，以及国内外相关领域内前人所做的工作及研究概况，明确提出本文的目的。

注意尽量避免与文题及摘要文字上的雷同。

2.5正文层次序号用1…… 1.1…… 1.1.1……表示。

层次序号后写明各层次标题。

2.6实验材料写明实验材料来源、批号及合格证号等。

论文中实验药材的原植（动、矿）物名称要求使用《中华人民共和国药典》所规定的名称，并注明鉴定人姓名、职称及其工作单位。

处方需写出全部药物组成、剂量及主要制备工艺。

写明实验主要仪器设备名称、型号、生产厂家及试剂的规格。

2.7数字与有效数字数字作为量词及序词，一律用阿拉伯数字，但古籍文献的卷次、页码，农历及我国清代以前的历史纪年用汉字。

固定词语中作词素的数字用汉字，如二倍体、十二指肠等。

应注意有效数字的取舍，测得的数据不得超过其测量仪器的精密度。

作者应认真核实，确保来稿中各项数据的准确无误。

2.8计量单位和符号遵照国家法定标准及有关国际规定规范使用量和单位的名称、符号，如：L（升），s（秒），min （分钟），h（小时），d（天），lx（勒[克斯]）等。

《药学学报》编辑部投稿须知《药学学报》是由中国药学会、中国医学科学院药物研究所共同主办的药学综合性学术类月刊，主要报道药学各学科领域基础和应用基础研究的原始性、创新性科研成果，面向国内外公开发行，是中国自然科学核心期刊，被国内外主要检索系统收录。

本刊荣获首届国家期刊奖，入选中国期刊方阵双高(高知名度、高学术水平)期刊，荣获第2届国家期刊奖百种重点科技期刊和第3届中国科技优秀期刊奖二等奖，从2002～2010年连续9届被评为“中国百种杰出学术期刊”。

1 稿件内容刊登的稿件包括综述与述评、研究论文、研究简报和学术动态等。

来稿要求论点明确、数据可靠、结构严密、层次分明、文字精炼。

综述与述评对当前药学的研究热点和前沿领域进行总结、评述，并结合作者在本领域的工作发表见解。

研究论文报道药学领域具有原始性和创新性的研究成果。

研究简报报道药学领域具有原始性、创新性的阶段性研究成果。

学术动态报道药学领域发展动向、著名学者的报告。

2投稿方式电子邮件投稿（即网络投稿）本刊所接收的电子稿件，一律要求用Word文档电子版格式（图表均插入文中，并同时提供一份JPG图片格式单独发送），采用网上发送Email邮件方式投稿，并在邮件主题中注明“投稿”字样。

本刊全国统一投稿电子邮箱E-mail：yxxbzz@；邮寄来稿请尽量用小四号字打印在A4纸上，凡字迹潦草、涂改不清的稿件，恕不受理。

来稿须附单位推荐信（电子邮件投稿请拍照后以JPG格式的附件来邮），作者单位对文稿的真实性和保密性负责，并声明未一稿两投、不涉及保密、署名无争议等项，并注明第一作者姓名、性别、学历、职称、职务、单位、地址及邮码务必写清楚。

多作者稿署名时须征得其他作者同意，排好先后次序，接《稿件录用通知书》后不再进行改动。

为加快稿件处理速度、提高工作效率，条件允许的作者请尽量优先选择电子邮件的方式投稿，本刊全国统一投稿电子邮箱E-mail：yxxbzz@。

请作者尽量勿选择邮寄稿件，以免遗失或延误时间。

《中国药业》杂志学术类稿件投稿须知
佚名
【期刊名称】《中国药业》
【年(卷),期】2004(13)1
【摘要】1 投稿注意事项 1.1 文稿内容须符合本刊专业范围,即各类文章均应与“药”有关(纯医学诊断及护理等方面的学术稿件本刊恕不采用)。

1.2 文稿内容应具科学性、实用性和先进性。

1.3 文稿务求论点明确,论据可靠,数字准确,重点突出,层次清楚,文字精炼.引用资料请附参考文献。

全文字数以不超过500HD字为宜。

1.4 文稿须打印,文中的的数据、结构式、公式、符号、参考文献等请仔细核对,注意上下角标、英文大小写、希文、罗马数字的正规书写。

【总页数】1页(P38-38)
【正文语种】中文
【中图分类】R-5
【相关文献】
1.《仪器仪表用户》杂志社投稿须知及稿件要求 [J], 本刊编辑部
2.《中国药业》杂志学术类稿件投稿须知 [J],
3.《中国组织工程研究与临床康复》杂志2010年稿件规范细则稿件体例,英文表述,投稿须知 [J], 《中国组织工程研究与临床康复》杂志社中文部
4.中国科技论文统计源期刊、中国科技核心期刊《中国药业》杂志欢迎投稿！欢迎订阅 [J],
5.中国科技论文统计源期刊中国科技核心期刊《中国药业》杂志欢迎投稿欢迎订阅! [J],
因版权原因，仅展示原文概要，查看原文内容请购买。